Will genetics revolutionize medicine
作者： Neil A. Holtzman , Theresa M. Marteau
DOI: 10.1056/NEJM200007133430213
关键词: Alternative medicine 、 Form of the Good 、 Genetic testing 、 Medicine 、 MEDLINE 、 Genetics 、 Predictive testing
摘要: On both sides of the Atlantic, revolutionary claims have been made about ultimate impact genetics on clinical medicine. John Bell at Oxford has asserted that “within next decade genetic testing will be used widely for predictive in healthy people and diagnosis management patients. . The excitement field shifted to elucidation basis common diseases.”1 And United States director National Human Genome Research Institute, Francis Collins, stated good would come from mapping human . . .
uq.edu.au
georgetown.edu参考文章(41)
E Treacy, B Childs, C R Scriver, Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison. American Journal of Human Genetics. ,vol. 56, pp. 359- 367 ,(1995)
Patricia F. Adams, Veronica Benson, Current Estimates from the National Health Interview Survey, 1991 ,(1992)
Neil A. Holtzman, Ruth R. Faden, Gary A. Chase, Karen J. Hofman, Gail Geller, Barbara A. Bernhardt, Ellen S. Tambor, Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. American Journal of Human Genetics. ,vol. 55, pp. 626- 637 ,(1994)
J. Bell, The new genetics in clinical practice BMJ. ,vol. 316, pp. 618- 620 ,(1998) , 10.1136/BMJ.316.7131.618
Geoffrey Rose, Sick individuals and sick populations International Journal of Epidemiology. ,vol. 30, pp. 427- 432 ,(1985) , 10.1093/IJE/30.3.427
Piri L Welcsh, Kelly N Owens, Mary-Claire King, Insights into the functions of BRCA1 and BRCA2. Trends in Genetics. ,vol. 16, pp. 69- 74 ,(2000) , 10.1016/S0168-9525(99)01930-7
Ida Martinelli, Elisabetta Sacchi, Gianluca Landi, Emanuela Taioli, Francesca Duca, Pier Mannuccio Mannucci, High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. The New England Journal of Medicine. ,vol. 338, pp. 1793- 1797 ,(1998) , 10.1056/NEJM199806183382502
N J Wald, A K Hackshaw, C D Frost, When can a risk factor be used as a worthwhile screening test BMJ. ,vol. 319, pp. 1562- 1565 ,(1999) , 10.1136/BMJ.319.7224.1562
Eric Lander, Leonid Kruglyak, Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results Nature Genetics. ,vol. 11, pp. 241- 247 ,(1995) , 10.1038/NG1195-241
V.K. Lee, D.B. Loeb, F.A. Mapa, E. McClelland, N.C. Meyer, G.A. Mintier, N. Moeller, T. Moore, E. Morikang, C.E. Prass, L. Quintana, S.M. Starnes, R.C. Schatzman, K.J. Brunke, D.T. Drayna, N.J. Risch, B.R. Bacon, R.K. Wolff, J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, A. Basava, F. Dormishian, R. Domingo, M.C. Ellis, A. Fullan, L.M. Hinton, N.L. Jones, B.E. Kimmel, G.S. Kronmal, P. Lauer, A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis Nature Genetics. ,vol. 13, pp. 399- 408 ,(1996) , 10.1038/NG0896-399